振东制药(300158.SZ)：上半年净利润793.13万元，同比下降74.13%

Group 1 - The company reported a revenue of 1.457 billion yuan for the first half of 2025, representing a year-on-year decrease of 3.30% [1] - The net profit attributable to shareholders of the listed company was 7.9313 million yuan, down 74.13% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -8.1764 million yuan [1] - The basic earnings per share were 0.0077 yuan [1]